PrescribedRX review
Provider messaging and included supplies are described, but the three-month plan renews every ten weeks.
The verdict
PrescribedRX describes ongoing clinical messaging and dose adjustments within its compounded injection plans. The timing deserves clarification before starting: each offer advertises a three-month supply while setting renewal every ten weeks.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The platform offers several prescription treatment categories, including compounded semaglutide and tirzepatide. A clinician decides whether treatment fits after reviewing eligibility information.
Who writes the prescription, and what do they see?
The product pages say a licensed provider reviews the application within 48 hours. PrescribedRX says it does not produce the medication. Ask which medical practice and pharmacy will handle your prescription before enrollment.
The listed plans include injection supplies, priority shipping, and care-team messaging. Payment is collected before review, with a full refund stated when the provider finds treatment inappropriate. Renewal is described as recurring at the same package price.
What happens when the dose goes up?
A provider directs dose increases. The pages promise a consistent price across doses, but do not publish a detailed milligram ladder. Ask how dose changes affect the amount dispensed and the timing of the next refill.
What the price includes
Semaglutide requires $420 upfront, presented as $140 monthly; tirzepatide requires $597, presented as $199 monthly. Both are labeled three-month plans yet billed every ten weeks. No independently purchasable monthly option appeared in the rendered pages.
What it claims, and what it cites
Both injection offers are compounded preparations. Their safety notices distinguish them from FDA-approved drugs. Evidence from branded semaglutide or tirzepatide trials does not verify these specific preparations.
Where it holds up, and where it does not
- Strength: Clinical messaging is included
- Strength: Injection supplies and priority shipping listed
- Strength: Dose changes do not change the stated package price
- Limitation: Three-month supply and ten-week renewal differ
- Limitation: No separate monthly payment displayed
- Limitation: Specific dispensing pharmacy needs confirmation
What the evidence says about this kind of treatment
The assessment above is about PrescribedRX. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A patient comfortable with a prepaid supply after clarifying refill timing with the care team.
- Wrong for
- Someone who needs an unambiguous single-month trial of treatment.
The evidence behind what PrescribedRX prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How PrescribedRX compares
| Seller | Who it suits | Go |
|---|---|---|
 Yucca Health | Buyers who want the whole ladder visible before intake and may not stay six months | See Yucca Health → |
 Zera Health | A reader who budgets from the monthly rate printed beside the first-month offer. | See Zera Health → |
| CLYR Health | Buyers who want the cost of each dose tier published before the first injection | See CLYR Health → |
More GLP-1 telehealth sellers reviews: PeterMDRxSpan MDSesame CareShedRxSkinnyRxSnagRx
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- How often does PrescribedRX renew?
- The current injection pages say every ten weeks, despite describing a three-month plan. Confirm that schedule and the amount supplied before paying.
- Are the displayed monthly amounts monthly payments?
- The visible offers collect $420 for semaglutide or $597 for tirzepatide upfront. The smaller figures are package averages.